Burrage Capital Management as of Dec. 31, 2020
Portfolio Holdings for Burrage Capital Management
Burrage Capital Management holds 25 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Epizyme | 7.7 | $10M | 931k | 10.86 | |
| Ptc Therapeutics I (PTCT) | 7.5 | $9.8M | 161k | 61.03 | |
| NeoGenomics (NEO) | 7.3 | $9.6M | 179k | 53.84 | |
| Iveric Bio | 7.3 | $9.6M | 1.4M | 6.91 | |
| Protalix Biotherapeutics (PLX) | 6.8 | $9.0M | 2.5M | 3.63 | |
| Turning Point Therapeutics I | 6.7 | $8.8M | 73k | 121.85 | |
| Mei Pharma | 6.5 | $8.5M | 3.2M | 2.64 | |
| BioCryst Pharmaceuticals (BCRX) | 6.3 | $8.2M | 1.1M | 7.45 | |
| Y Mabs Therapeutics (YMAB) | 4.3 | $5.7M | 115k | 49.51 | |
| Insmed (INSM) | 3.9 | $5.1M | 155k | 33.29 | |
| Cytokinetics (CYTK) | 3.9 | $5.1M | 246k | 20.78 | |
| Apellis Pharmaceuticals (APLS) | 3.5 | $4.7M | 81k | 57.20 | |
| Aurinia Pharmaceuticals (AUPH) | 3.5 | $4.7M | 336k | 13.83 | |
| Frequency Therapeutics | 3.3 | $4.4M | 125k | 35.26 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.1 | $4.0M | 126k | 32.01 | |
| Inozyme Pharma (INZY) | 2.7 | $3.5M | 171k | 20.64 | |
| Intellia Therapeutics (NTLA) | 2.7 | $3.5M | 64k | 54.40 | |
| Fulcrum Therapeutics (FULC) | 2.4 | $3.2M | 272k | 11.71 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $3.2M | 224k | 14.11 | |
| Mirum Pharmaceuticals (MIRM) | 2.2 | $2.8M | 162k | 17.46 | |
| Merus N V (MRUS) | 1.7 | $2.3M | 131k | 17.53 | |
| G1 Therapeutics (GTHX) | 1.6 | $2.1M | 118k | 17.99 | |
| Avrobio Ord (AVRO) | 1.5 | $2.0M | 146k | 13.94 | |
| Black Diamond Therapeutics (BDTX) | 0.9 | $1.1M | 35k | 32.04 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $134k | 15k | 8.93 |
